KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Other Working Capital Changes: 2020-2025

Historic Other Working Capital Changes for Recursion Pharmaceuticals (RXRX) over the last 6 years, with Sep 2025 value amounting to -$3.5 million.

  • Recursion Pharmaceuticals' Other Working Capital Changes fell 190.09% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.4 million, marking a year-over-year decrease of 31.07%. This contributed to the annual value of -$28.0 million for FY2024, which is 31.74% up from last year.
  • As of Q3 2025, Recursion Pharmaceuticals' Other Working Capital Changes stood at -$3.5 million, which was down 13.29% from -$3.1 million recorded in Q2 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Other Working Capital Changes peaked at $144.7 million during Q1 2022, and registered a low of -$27.1 million during Q1 2025.
  • For the 3-year period, Recursion Pharmaceuticals' Other Working Capital Changes averaged around -$9.4 million, with its median value being -$10.2 million (2023).
  • In the last 5 years, Recursion Pharmaceuticals' Other Working Capital Changes crashed by 1,190.53% in 2021 and then skyrocketed by 5,013.11% in 2022.
  • Over the past 5 years, Recursion Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$2.5 million in 2021, then crashed by 447.00% to -$13.7 million in 2022, then surged by 43.58% to -$7.7 million in 2023, then grew by 26.59% to -$5.7 million in 2024, then tumbled by 190.09% to -$3.5 million in 2025.
  • Its Other Working Capital Changes stands at -$3.5 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$27.1 million for Q1 2025.